The use of misoprostol for abortion at < or = 9 weeks' gestation.

Carbonell, J L; Varela, L; Velazco, A; Fernández, C; Sánchez, C

Carbonell, J L; Varela, L; Velazco, A; Fernández, C; Sánchez, C.

Affiliation

Carbonell JL; Hospital Docente Gineco-Obstétrico Eusebio Hernández (Maternidad Obrena), Ciudad de la Habana, Cuba.

Eur J Contracept Reprod Health Care ; 2(3): 181-5, 1997 Sep.

Article in En | MEDLINE | ID: mdl-9678090

Subject(s)

Abortifacient Agents, Nonsteroidal; Abortion, Induced/methods; Misoprostol; Abortifacient Agents, Nonsteroidal/administration & dosage; Abortifacient Agents, Nonsteroidal/adverse effects; Administration, Intravaginal; Adult; Female; Gestational Age; Humans; Misoprostol/administration & dosage; Misoprostol/adverse effects; Pregnancy; Pregnancy Trimester, First; Self Administration; Time Factors; Ultrasonography; Uterine Hemorrhage/chemically induced; Uterus/diagnostic imaging

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Abortifacient Agents, Nonsteroidal / Misoprostol / Abortion, Induced Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Eur J Contracept Reprod Health Care Journal subject: MEDICINA REPRODUTIVA / SERVICOS DE PLANEJAMENTO FAMILIAR Year: 1997 Document type: Article Affiliation country: Cuba Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links